Author:
Vaz Clint,Jose Nisha K.,Tom Jeremiah Jacob,Goodman Georgia R.,Lee Jasper S.,Padappayil Rana Prathap,Madathil Manjunath,O’Cleirigh Conall,Rodrigues Rashmi,Chai Peter R.
Abstract
Abstract
Background
Tuberculosis (TB) represents a significant public health threat in India. Adherence to antitubercular therapy (ATT) is the key to reducing the burden of this infectious disease. Suboptimal adherence to ATT and lack of demonstrated feasibility of current strategies for monitoring ATT adherence highlights the need for alternative adherence monitoring systems.
Methods
A quantitative survey was conducted to assess the acceptance of and willingness to use a digital pill system (DPS) as a tool for monitoring ATT adherence among stakeholders directly involved in the management of patients with TB in India. Participants reviewed a video explaining the DPS and completed a survey, which covered sociodemographics, degree of involvement with TB patients, initial impressions of the DPS, and perceived challenges for deploying the technology in India. Participants were also asked to interpret mock DPS adherence data.
Results
The mean age was 34.3 (SD = 7.3), and participants (N = 50) were predominantly male (70%). The sample comprised internists (52%) and pulmonologists (30%), with a median of 4 years’ experience (IQR 3, 6) in the management of TB patients. No participants had previously used a DPS, but some reported prior awareness of the technology (22%). Most reported that they would recommend use of a DPS to patients on ATT (76%), and that they would use a DPS in both the intensive and continuation phases of TB management (64%). The majority viewed the DPS (82%) as a useful alternative to directly observed therapy-short course (DOTS), particularly given the ongoing COVID-19 pandemic. Participants reported that a DPS would be most effective in patients at risk of nonadherence (64%), as well as those with past nonadherence (64%). Perceived barriers to DPS implementation included lack of patient willingness (92%), cost (86%), and infrastructure constraints (66%). The majority of participants were able to accurately interpret patterns of adherence (80%), suboptimal adherence (90%), and frank nonadherence (82%) when provided with mock DPS data.
Conclusions
DPS are viewed as an acceptable, feasible, and useful technology for monitoring ATT adherence by stakeholders directly involved in TB management. Future investigations should explore patient acceptance of DPS and pilot demonstration of the system in the TB context.
Funder
Department of Emergency Medicine, Brigham and Women's Hospital, MA, USA
National Institute on Drug Abuse
National Institute of Nursing Research
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. World Health Organization. The End TB Strategy. Accessed July 3, 2022. https://www.who.int/publications/i/item/WHO-HTM-TB-2015.19.
2. World Health Organization. Global Tuberculosis Report. Accessed March 3, 2022. https://www.who.int/publications/i/item/9789240037021.
3. Dhamnetiya D, Patel P, Jha RP, Shri N, Singh M, Bhattacharyya K. Trends in incidence and mortality of tuberculosis in India over past three decades: a joinpoint and age-period-cohort analysis. BMC Pulm Med. 2021;21(1):375. https://doi.org/10.1186/s12890-021-01740-y.
4. Arinaminpathy N, Chin DP, Sachdeva KS, et al. Modelling the potential impact of adherence technologies on tuberculosis in India. Int J Tuberc Lung Dis. 2020;24(5):526–33. https://doi.org/10.5588/ijtld.19.0472.
5. Valencia S, León M, Losada I, Sequera VG, Fernández Quevedo M, García-Basteiro AL. How do we measure adherence to anti-tuberculosis treatment? Expert Rev Anti Infect Ther. 2017;15(2):157–65. https://doi.org/10.1080/14787210.2017.1264270.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献